» Go to news main
Molly Appeal paves the way to precision cancer treatment
Posted by Melanie Jollymore on
November 24, 2017
in
News
2017 Molly Appeal lead researchers (left to right) Wenda Greer, Zhaolin Xu and Paola Marignani. (Group photos by Danny Abriel; additional photos courtesy Dalhousie Medical Research Foundation)
A group of Dalhousie Medical School researchers is spearheading a new initiative to develop personalized cancer treatments, with support from Dalhousie Medical Research Foundation’s 2017-18 Molly Appeal.
“Every person’s cancer is as unique as their fingerprints,” says Dr. Paola Marignani, an internationally known cancer researcher and professor in Dalhousie’s Department of Biochemistry & Molecular Biology who’s leading this year’s Molly Appeal research initiative.
Read more on Dal News.
Recent News
- Dr. Shashi Gujar receives Canadian Cancer Society Emerging Scholar Award
- Dal Health researcher part of largest vaccine safety study in Canadian history
- Doctor for a Day at DMNB workshops go virtual for New Brunswick March break
- One year later: Faculty of Medicine dean reflects on the COVID‑19 upheaval
- Med students create video series to dispel COVID myths
- Government of Canada invests in research through CIHR Project Grant program
- #ChooseToChallenge: The First Female Medical Graduate from Dalhousie
- Dr. Gaynor Watson‑Creed named to federal Task Force on Women in the Economy